Refine by
Early Disease Detection Suppliers & Manufacturers
28 companies found
based in, MASSACHUSETTS (USA)
MtoZ Biolabs is an integrate contract research organization (CRO) providing advanced proteomics, metabolomics, bioinformatics, and biopharmaceutical analysis services to researchers in biochemistry, biotechnology, and biopharmaceutical fields. The ...
based inRockville, MARYLAND (USA)
20/20 GeneSystems (“20/20”) is focused on on reducing cancer deaths worldwide through its years of experience in the development and use of cancer biomarker test development. By leveraging this expertise and combining it with advanced machine ...
20/20 GeneSystems developed PAULA’s Test, a blood test for early detection of lung cancer. It is available in the USA through licensed medical professionals. Testing is performed at 20/20’s CLIA licensed laboratory, Genesys Biolabs (CLIA ...
based inAarhus C, DENMARK
Cercare Medical is based on +25 years of research in perfusion imaging and artificial intelligence. Our novel biomarkers provide unparalleled patient insights. We are bridging the gap between science and clinical practice. With our amazing ...
based inSan Diego, CALIFORNIA (USA)
Nucleix is a liquid biopsy company revolutionizing cancer treatment with earlier disease detection, at a time when intervention can bring the greatest impact for patients. Leveraging PCR-based epigenetics, our pioneering testing approach uses ...
based inSt. Louis, MISSOURI (USA)
C₂N’s Diagnostics’ vision is to bring Clarity Through Innovation™. It focuses its therapeutic discovery efforts around mechanism-based approaches to prevent or stop the progression of human neurological disorders. Diagnostic efforts revolve around ...
The PrecivityAD™ test is an innovative new blood test intended for use in patients with cognitive impairment. The test aims to help physicians better determine the presence or absence of amyloid plaques in the brain, a hallmark sign of ...
based inBillerica, MASSACHUSETTS (USA)
We are on a mission to change the way in which healthcare is provided by giving researchers the ability to closely examine the continuum from health to disease. In order to make this vision a reality, we brought together the most experienced ...
based inWellesley Heights, MASSACHUSETTS (USA)
Novel point-of-care diagnostics for earlier disease detection. SANO Diagnostics is developing a range of disposable, cost-effective point-of-care diagnostics to detect the early onset of inflammation in several disease states. We are a development ...
based inSuffern, NEW YORK (USA)
An advanced diagnostic platform that leverages artificial intelligence (AI) enabled tissue analysis and 3D imaging to reliably detect precancerous cells. CDx provides an integrated solution of enhanced tissue sampling and an AI-assisted diagnostic ...
based inLittleport, UNITED KINGDOM
Roboscientific is developing its VOC Monitoring Systems to provide a reliable, consistent, fast, affordable, non-invasive method of monitoring indoor environments to alert when a Covid-19 infected person is in the space. The Roboscientific Air ...
based inGoettingen, GERMANY
Fassisi GmbH is a manufacturer and developer of on-site rapid test systems, with a focus on the veterinary sector. The quality of our iVD products results from our more than 10 years of experience in the development and production of rapid test ...
based inOakland, CALIFORNIA (USA)
Eko is your all-in-one screening and telemedicine solution, helping you detect cardiac conditions easier and provide timely care from anywhere. The ability to listen is the ability to care. Eko understands how important listening can be for ...
based inParis, FRANCE
We are a multidisciplinary team of clinicians, technologists and behavioural experts who have come together to solve some of the biggest challenges in healthcare. Building on multi-year clinical studies on the impact of patient reported symptoms on ...
based inAustin, TEXAS (USA)
Natera is a global leader in cell-free DNA (cfDNA) testing, dedicated to oncology, women’s health, and organ health. We aim to make personalized genetic testing and diagnostics part of the standard of care to protect health and inform earlier, more ...
Renasight is a test to determine if there is a genetic cause for an individual’s kidney disease or if there is an increased hereditary risk due to family history. The test uses a blood or saliva sample to test 385 genes associated with chronic ...
based inCambridge, UNITED KINGDOM
Owlstone Medical is developing a breathalyzer for disease. With a goal to find ways to improve non-invasive diagnostics for respiratory diseases, liver diseases, cancer, digestive health and other conditions. Our mission is to save 100,000 lives and ...
Non-invasive analysis of biomarkers on breath in early detection and precision medicine. Exhaled breath is more than just air, it contains over 1,000 volatile organic compounds (VOCs) as well as microscopic aerosol particles, also known as ...
based inNorcross, GEORGIA (US) (USA)
Create a revolution in medical imaging through our advanced Computed Tomography technology. We believe our Koning Breast CT will dramatically improve the way clinicians visualize and evaluate breast tissue. Future versions of our technology are ...
based inCamarillo, CALIFORNIA (USA)
Hygiena delivers rapid microbial detection, monitoring, and identification solutions to a wide range of industries, including food and beverage, health care, hospitality, pharmaceuticals, and personal care. Utilizing advanced technologies and ...
based inCoralville, IOWA (USA)
In April 2018, Digital Diagnostics(formerly known as IDx) became the first company to ever receive FDA clearance for an AI diagnostic platform that makes a diagnosis without physician input at the point-of-care. This achievement did not happen ...
IDx-DR is an AI diagnostic system that autonomously diagnoses patients for diabetic retinopathy (including macular ...
based inAbercynon, UNITED KINGDOM
Imspex provides cutting-edge analytics solutions where early warning signals are needed. Our versatile combination of gas chromatography (GC) and ion mobility spectrometry (IMS) has already proven itself in medical detection and medical diagnosis ...
based inCambridge, MASSACHUSETTS (USA)
Arc Bio is revolutionizing microbial detection with proprietary, turnkey metagenomic Next-Generation Sequencing (mNGS) workflow and software solutions for fast, precise, and cost-effective analyses. Arc Bio is revolutionizing microbial detection by ...
At Arc Bio, we believe that metagenomics has exciting applications in both established (e.g., infectious disease) and emerging (e.g., onco-microbiome) research areas. That is why we offer a full suite of bespoke wet lab and dry lab services that ...
based inWest Lafayette, INDIANA (USA)
Tymora Analytical Operations provides diagnostic development and exosome proteomics contract services and products for improved cancer research. Tymora’s primary goal is to enable the shift from tissue to liquid biopsy. Our new technologies allow ...
